MyFinsight
Home
About
Contact
lgnd: the income statement
Download
Download image
Financial Royalty Assets
$6,425K
Intangible Royalty Assets
$40,161K
Contract Revenue And
Other Income
$58,203K
Material Sales Captisol
$10,672K
Royalty
$46,586K
Interest income
$3,874K
(187.60%↑ Y/Y)
Gain (loss) from
change in fair value of...
$75,887K
Gain (loss) from
short-term investments
$7,798K
(223.97%↑ Y/Y)
Total revenues and
other income
$115,461K
(122.85%↑ Y/Y)
Total non-operating
income (expenses), net
$86,206K
(1009.15%↑ Y/Y)
Operating income (loss)
$54,931K
(1647.73%↑ Y/Y)
Other non-operating
expense, net
-$443K
(96.45%↑ Y/Y)
Interest expense
$910K
(22.81%↑ Y/Y)
Total operating costs
and expenses
$60,530K
(24.37%↑ Y/Y)
Fair value
adjustments to partner...
$833K
(110.66%↑ Y/Y)
Income (loss) before
income taxes
$141,137K
(2326.49%↑ Y/Y)
General and
administrative
$28,446K
(16.22%↑ Y/Y)
Research and development
$21,019K
(270.38%↑ Y/Y)
Amortization of intangibles
$8,097K
(-1.95%↓ Y/Y)
Cost of captisol
$3,801K
(55.21%↑ Y/Y)
Net income (loss)
$117,273K
(1735.15%↑ Y/Y)
Income tax expense
$23,864K
(2764.83%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
LIGAND PHARMACEUTICALS INC (LGND)
LIGAND PHARMACEUTICALS INC (LGND)